Sosei Heptares Eyes $3bn Sales From IBD Drug Returned By GSK

Chris Cargill
Chris Cargill • Source: Sosei Heptares
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category